These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30561318)

  • 1. Seroepidemiology of Parechovirus A3 Neutralizing Antibodies, Australia, the Netherlands, and United States.
    Karelehto E; Brouwer L; Benschop K; Kok J; Basile K; McMullan B; Rawlinson W; Druce J; Nicholson S; Selvarangan R; Harrison C; Lankachandra K; van Eijk H; Koen G; de Jong M; Pajkrt D; Wolthers KC
    Emerg Infect Dis; 2019 Jan; 25(1):148-152. PubMed ID: 30561318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human parechovirus seroprevalence in Finland and the Netherlands.
    Westerhuis B; Kolehmainen P; Benschop K; Nurminen N; Koen G; Koskiniemi M; Simell O; Knip M; Hyöty H; Wolthers K; Tauriainen S
    J Clin Virol; 2013 Sep; 58(1):211-5. PubMed ID: 23891146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroepidemiology of human parechovirus types 1, 3, and 6 in Yamagata, Japan, in 2014.
    Tanaka S; Aoki Y; Matoba Y; Yahagi K; Itagaki T; Matsuzaki Y; Mizuta K
    Microbiol Immunol; 2016 Dec; 60(12):854-858. PubMed ID: 27925289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of High Neutralizing Antibody Titers After Neonatal and Early Infantile Infection with Parechovirus-A3.
    Izumita R; Aizawa Y; Watanabe K; Saitoh A
    Pediatr Infect Dis J; 2019 Jul; 38(7):e159-e161. PubMed ID: 30431525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of parechovirus A1, A3 and A4 antibodies in Yamagata, Japan, between 1976 and 2017.
    Mizuta K; Komabayashi K; Aoki Y; Itagaki T; Ikeda T
    J Med Microbiol; 2020 Dec; 69(12):1381-1387. PubMed ID: 33170118
    [No Abstract]   [Full Text] [Related]  

  • 6. Association Between Neutralizing Antibody Titers against Parechovirus A3 in Maternal and Cord Blood Pairs and Perinatal Factors.
    Shimizu H; Hashimoto K; Sato M; Sato A; Sato M; Maeda H; Kyozuka H; Kawasaki Y; Yokoyama T; Fujimori K; Yasumura S; Hosoya M
    J Pediatric Infect Dis Soc; 2020 Jul; 9(3):320-325. PubMed ID: 31107961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood Outcomes Following Parechovirus Infections in a US Young Infant Cohort.
    Kilbride H; Jackson MA; Selvarangan R
    Pediatr Infect Dis J; 2021 Apr; 40(4):295-299. PubMed ID: 33710974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parechovirus A3 (PeV-A3)-associated myalgia/myositis occurs irrespective of its genetic cluster: a longitudinal molecular epidemiology of PeV-A3 in Yamagata, Japan between 2003 and 2016.
    Mizuta K; Aoki Y; Komabayashi K; Tanaka S; Yamakawa T; Shimizu Y; Itagaki T; Katsushima F; Katsushima Y; Ikeda T
    J Med Microbiol; 2019 Mar; 68(3):424-428. PubMed ID: 30556799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parechovirus A Infections in Healthy Australian Children During the First 2 Years of Life: A Community-based Longitudinal Birth Cohort Study.
    Wang CYT; Ware RS; Lambert SB; Mhango LP; Tozer S; Day R; Grimwood K; Bialasiewicz S
    Clin Infect Dis; 2020 Jun; 71(1):116-127. PubMed ID: 31406985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate Immune Responses in Serum and Cerebrospinal Fluid From Neonates and Infants Infected With Parechovirus-A3 or Enteroviruses.
    Habuka R; Aizawa Y; Izumita R; Domon H; Terao Y; Takihara H; Okuda S; Saitoh A
    J Infect Dis; 2020 Jul; 222(4):681-689. PubMed ID: 32201899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological survey in the Finnish human population implies human-to-human transmission of Ljungan virus or antigenically related viruses.
    Jääskeläinen AJ; Voutilainen L; Lehmusto R; Henttonen H; Lappalainen M; Kallio-Kokko H; Vaheri A; Vapalahti O
    Epidemiol Infect; 2016 Apr; 144(6):1278-85. PubMed ID: 26489898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Memory B Cells Producing Potent Cross-Neutralizing Antibodies against Human Parechovirus: Implications for Prevalence, Treatment, and Diagnosis.
    Westerhuis BM; Benschop KS; Koen G; Claassen YB; Wagner K; Bakker AQ; Wolthers KC; Beaumont T
    J Virol; 2015 Aug; 89(15):7457-64. PubMed ID: 25948742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Parechovirus 1, 3 and 4 Neutralizing Antibodies in Dutch Mothers and Infants and Their Role in Protection Against Disease.
    Karelehto E; Wildenbeest JG; Benschop KSM; Koen G; Rebers S; Bouma-de Jongh S; Westerhuis BM; de Jong MD; Pajkrt D; Wolthers KC
    Pediatr Infect Dis J; 2018 Dec; 37(12):1304-1308. PubMed ID: 30382954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Protection against Asian Enterovirus 71 Outbreak Strains by Cross-neutralizing Capacity of Serum from Dutch Donors, The Netherlands.
    van der Sanden SM; Koen G; van Eijk H; Koekkoek SM; de Jong MD; Wolthers KC
    Emerg Infect Dis; 2016 Sep; 22(9):1562-9. PubMed ID: 27533024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Evolution and Epidemiology of Parechovirus-A3 in Japan, 1997-2019.
    Aizawa Y; Kasamatsu T; Nagasawa K; Watanabe K; Saitoh A
    J Infect Dis; 2023 Jan; 227(2):288-294. PubMed ID: 35608411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a serological assay based on a synthetic peptide selected from the VP0 capsid protein for detection of human parechoviruses.
    Abed Y; Wolf D; Dagan R; Boivin G
    J Clin Microbiol; 2007 Jun; 45(6):2037-9. PubMed ID: 17442804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal parechovirus A (PeV-A) shedding, serostatus, and the risk of central nervous system PeV-A infections in infants.
    Klatte JM; Harrison CJ; Pate B; Queen MA; Neuhart J; Jackson MA; Selvarangan R
    J Clin Virol; 2021 Sep; 142():104939. PubMed ID: 34390928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodevelopmental outcomes of newborns and infants with parechovirus and enterovirus central nervous infection: a 5-year longitudinal study.
    van Hinsbergh T; Elbers RG; Bouman Z; van Furth M; Obihara C
    Eur J Pediatr; 2022 May; 181(5):2005-2016. PubMed ID: 35119491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of Parechovirus A3 as the Leading Cause of Central Nervous System Infection, Surpassing Any Single Enterovirus Type, in Children in Kansas City, Missouri, USA, from 2007 to 2016.
    Sasidharan A; Banerjee D; Harrison CJ; Selvarangan R
    J Clin Microbiol; 2021 May; 59(6):. PubMed ID: 33692140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human parechovirus 1 infections in young children--no association with type 1 diabetes.
    Tauriainen S; Martiskainen M; Oikarinen S; Lönnrot M; Viskari H; Ilonen J; Simell O; Knip M; Hyöty H
    J Med Virol; 2007 Apr; 79(4):457-62. PubMed ID: 17311340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.